These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 22845549)

  • 1. The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury.
    Monteiro TP; El-Jaick KB; Jeovanio-Silva AL; Brasil PE; Costa MJ; Rolla VC; de Castro L
    J Clin Pharm Ther; 2012 Dec; 37(6):712-8. PubMed ID: 22845549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTT1 and GSTM1 gene deletions are not associated with hepatotoxicity caused by antitubercular drugs.
    Chatterjee S; Lyle N; Mandal A; Kundu S
    J Clin Pharm Ther; 2010 Aug; 35(4):465-70. PubMed ID: 20853551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity.
    Singla N; Gupta D; Birbian N; Singh J
    Tuberculosis (Edinb); 2014 May; 94(3):293-8. PubMed ID: 24637014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP2E1, GSTM1 and GSTT1 genetic polymorphisms and susceptibility to antituberculosis drug-induced hepatotoxicity: a nested case-control study.
    Tang SW; Lv XZ; Zhang Y; Wu SS; Yang ZR; Xia YY; Tu DH; Deng PY; Ma Y; Chen DF; Zhan SY
    J Clin Pharm Ther; 2012 Oct; 37(5):588-93. PubMed ID: 22335459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTT1 and GSTM1 null mutations and adverse reactions induced by antituberculosis drugs in Koreans.
    Kim SH; Kim SH; Yoon HJ; Shin DH; Park SS; Kim YS; Park JS; Jee YK
    Tuberculosis (Edinb); 2010 Jan; 90(1):39-43. PubMed ID: 20036620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSTM1 and GSTT1 null polymorphisms and susceptibility to anti-tuberculosis drug-induced liver injury: a meta-analysis.
    Tang N; Deng R; Wang Y; Lin M; Li H; Qiu Y; Hong M; Zhou G
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):17-25. PubMed ID: 23232001
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Jaramillo-Valverde L; Levano KS; Tarazona DD; Vasquez-Dominguez A; Toledo-Nauto A; Capristano S; Sanchez C; Tarazona-Santos E; Ugarte-Gil C; Guio H
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased risk of antituberculosis drug-induced hepatotoxicity in individuals with glutathione S-transferase M1 'null' mutation.
    Roy B; Chowdhury A; Kundu S; Santra A; Dey B; Chakraborty M; Majumder PP
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1033-7. PubMed ID: 11595069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSTM1 and GSTT1 genetic polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity: an updated meta-analysis.
    Li C; Long J; Hu X; Zhou Y
    Eur J Clin Microbiol Infect Dis; 2013 Jul; 32(7):859-68. PubMed ID: 23377313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population.
    Gupta VH; Singh M; Amarapurkar DN; Sasi P; Joshi JM; Baijal R; H R PK; Amarapurkar AD; Joshi K; Wangikar PP
    Ann Hepatol; 2013; 12(6):959-65. PubMed ID: 24114827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of liver injury in Uyghur patients treated for TB in Xinjiang Uyghur autonomous region, China, and its association with hepatic enzyme polymorphisms nat2, cyp2e1, gstm1 and gstt1.
    Xiang Y; Ma L; Wu W; Liu W; Li Y; Zhu X; Wang Q; Ma J; Cao M; Wang Q; Yao X; Yang L; Wubuli A; Merle C; Milligan P; Mao Y; Gu J; Xin X
    PLoS One; 2014; 9(1):e85905. PubMed ID: 24465778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective observational study to evaluate Glutathione S-transferase gene polymorphism and its association with Antitubercular drugs induced liver injury in tertiary hospital.
    Akhtar J; Singh S; Verma AK; Pal R; Nath R
    Indian J Tuberc; 2022 Jul; 69(3):341-346. PubMed ID: 35760484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury.
    Feng FM; Guo M; Chen Y; Li SM; Zhang P; Sun SF; Zhang GS
    Genet Mol Res; 2014 Nov; 13(4):9463-71. PubMed ID: 25501156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity.
    Ueda K; Ishitsu T; Seo T; Ueda N; Murata T; Hori M; Nakagawa K
    Pharmacogenomics; 2007 May; 8(5):435-42. PubMed ID: 17465707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione-S-transferase genetic polymorphism and risk of hepatotoxicity to antitubercular drugs in a North-African population: A case-control study.
    Chbili C; Fathallah N; Laadhari C; Ouni B; Saguem S; Ben Fredj M; Abdelghani A; Ben Saad H; Ben Salem C
    Gene; 2022 Jan; 809():146019. PubMed ID: 34656741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms of CYP2E1 and GSTM1 loci and susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
    Sharma SK; Jha BK; Sharma A; Sreenivas V; Upadhyay V; Jaisinghani C; Singla R; Mishra HK; Soneja M
    Int J Tuberc Lung Dis; 2014 May; 18(5):588-93. PubMed ID: 24903797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury.
    Lucena MI; Andrade RJ; Martínez C; Ulzurrun E; García-Martín E; Borraz Y; Fernández MC; Romero-Gomez M; Castiella A; Planas R; Costa J; Anzola S; Agúndez JA;
    Hepatology; 2008 Aug; 48(2):588-96. PubMed ID: 18666253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.